Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Rheumatology
•
Rheumatoid Arthritis
•
NSAID
How do you manage rheumatoid arthritis that flares when an adjunctive NSAID is withdrawn despite otherwise stable DMARD therapy?
Related Questions
How do you approach choosing between subcutaneous and IV actemra for RA?
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
How do you approach the management of a patient with RA on methotrexate who has gingivitis or or frequent cavities?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
How can we approach tapering or discontinuing biologic DMARDs in patient in their 80s with well controlled rheumatoid arthritis?
Would you stop methotrexate or leflunomide if MCV increases after starting the medication with no other parameters of anemia or leukopenia?
